Proposed use: Ulcerative colitis Proposed forms: Oral capsules, nasal spray, injections, transdermal cream, rectal suppository Proposed use: Wound healing Proposed forms: Subcutaneous or intramuscular injection Secret To Weight Loss May Be Hiding In Your Gut, New Study Suggests Proposed use: Wound healing and inflammatory condition Proposed forms: Cream and gel Proposed use: Obesity and osteoporosis Proposed forms: Subcutaneous injection Proposed use: Cerebral ischemia (shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (chronic pain condition in the face) Proposed form: Intranasal spray, subcutaneous injection Click Here To Sign Up For Our Health Newsletter Proposed use: Opioid withdrawal, chronic insomnia, narcolepsy Proposed form: Subcutaneous injection Proposed use: Insomnia Proposed form: Subcutaneous injection Performance medicine and peptide expert Dr
Lugovi-Mihi L, Cvitanovi H, Djakovi I, Kuna M, eerko A
One of the trials represents phase 3 enrollment (ClinicalTrials.gov ID NCT03292822, ClinicalTrials.gov ID NCT04002024, ClinicalTrials.gov ID NCT02173054)
The dosing logic differs because MK-677 has a much longer half-life than Ipamorelin
The concern is for other medications a researcher might be taking that ARE metabolized by these enzymes
